MK-1903 | m-entrepreneurship.com

Product Name :
MK-1903

Search keywords :
MK-1903

drugId :
null

Target Vo:
Muscle-type nicotinic acetylcholine receptor

Target Vo Short Name :
Muscle-type nAChRs

Moa_Name:
Muscle-type nicotinic acetylcholine receptor agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Arena Pharmaceuticals Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Dyslipidemias

Termination Status :
Phase 2 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Atg12 Antibody
JNK1+JNK2+JNK3 Antibody
Glucosidase 2 subunit beta Antibody: Glucosidase 2 subunit beta Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 59 kDa., targeting to Glucosidase 2 subunit beta. It can be used for WB,IHC-P,ICC/IF assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts